Stocks and InvestingStocks and Investing
Thu, May 27, 2021
Wed, May 26, 2021
Tue, May 25, 2021
Mon, May 24, 2021
Fri, May 21, 2021

Eliana Merle Initiated (ZNTL) at Strong Buy and Held Target at $91 on, May 21st, 2021


Published on 2024-10-27 16:45:21 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $91 on, May 21st, 2021.

Eliana has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Eliana's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Eliana


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $80 on, Wednesday, May 19th, 2021
  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $64 on, Tuesday, April 13th, 2021